QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Erratum An erratum has been published All Versions of this Article: dmd.104.001735v1 33/2/243    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kalgutkar, A. S. Articles by Hop, C. E. C. A. Search for Related Content PubMed PubMed Citation Articles by Kalgutkar, A. S. Articles by Hop, C. E. C. A.

BIOACTIVATION OF THE NONTRICYCLIC ANTIDEPRESSANT NEFAZODONE TO A REACTIVE QUINONE-IMINE SPECIES IN HUMAN LIVER MICROSOMES AND RECOMBINANT CYTOCHROME P450 3A4

Pharmacokinetics, Dynamics and Metabolism Department (A.S.K., A.D.N.V., M.E.L., K.R.H., J.S., S.X.Z., C.C., C.E.C.A.H.), and Leads Progression Group (Y.A.A., F.L., Z.S.H.), Pfizer Global Research and Development, Groton, Connecticut

The therapeutic benefits of the antidepressant nefazodone have been hampered by several cases of acute hepatotoxicity/liver failure. Although the mechanism of hepatotoxicity remains unknown, it is possible that reactive metabolites of nefazodone play a causative role. Studies were initiated to determine whether nefazodone undergoes bioactivation in human liver microsomes to electrophilic intermediates. Following incubation of nefazodone with microsomes or recombinant P4503A4 in the presence of sulfydryl nucleophiles, conjugates derived from the addition of thiol to a monohydroxylated nefazodone metabolite were observed. Product ion spectra suggested that hydroxylation and sulfydryl conjugation occurred on the 3-chlorophenylpiperazine-ring, consistent with a bioactivation pathway involving initial formation of p-hydroxynefazodone, followed by its two-electron oxidation to the reactive quinone-imine intermediate. The formation of novel N-dearylated nefazodone metabolites was also discernible in these incubations, and 2-chloro-1,4-benzoquinone, a by-product of N-dearylation, was trapped with glutathione to afford the corresponding hydroquinone-sulfydryl adduct. Nefazodone also displayed NADPH-, time-, and concentration-dependent inactivation of P4503A4 activity, suggesting that reactive metabolites derived from nefazodone bioactivation are capable of covalently modifying P4503A4. A causative role for 2-chloro-1,4-benzoquinone and/or the quinone-imine intermediate(s) in nefazodone hepatotoxicity is speculated. Although the antianxiety agent buspirone, which contains a pyrimidine ring in place of the 3-chlorophenyl-ring, also generated p-hydroxybuspirone in liver microsomes, no sulfydryl conjugates of this metabolite were observed. This finding is consistent with the proposal that two-electron oxidation of p-hydroxybuspirone to the corresponding quinone-imine is less favorable due to differences in the protonation state at physiological pH and due to weaker resonance stabilization of the oxidation products as predicted from ab initio measurements.

This article has been cited by other articles:

				J. J. Xu, P. V. Henstock, M. C. Dunn, A. R. Smith, J. R. Chabot, and D. de Graaf Cellular Imaging Predictions of Clinical Drug-Induced Liver Injury Toxicol. Sci., September 1, 2008; 105(1): 97 - 105. [Abstract] [Full Text] [PDF]

				J. N. Bauman, K. S. Frederick, A. Sawant, R. L. Walsky, L. M. Cox, R. S. Obach, and A. S. Kalgutkar Comparison of the Bioactivation Potential of the Antidepressant and Hepatotoxin Nefazodone with Aripiprazole, a Structural Analog and Marketed Drug Drug Metab. Dispos., June 1, 2008; 36(6): 1016 - 1029. [Abstract] [Full Text] [PDF]

				B. Wen, L. Ma, A. D. Rodrigues, and M. Zhu Detection of Novel Reactive Metabolites of Trazodone: Evidence for CYP2D6-Mediated Bioactivation of m-Chlorophenylpiperazine Drug Metab. Dispos., May 1, 2008; 36(5): 841 - 850. [Abstract] [Full Text] [PDF]

				T. Kuuranne, A. Leinonen, W. Schanzer, M. Kamber, R. Kostiainen, and M. Thevis Aryl-Propionamide-Derived Selective Androgen Receptor Modulators: Liquid Chromatography-Tandem Mass Spectrometry Characterization of the in Vitro Synthesized Metabolites for Doping Control Purposes Drug Metab. Dispos., March 1, 2008; 36(3): 571 - 581. [Abstract] [Full Text] [PDF]

				K. P DeSanty and C. M Amabile Antidepressant-Induced Liver Injury Ann. Pharmacother., July 1, 2007; 41(7): 1201 - 1211. [Abstract] [Full Text] [PDF]

				M. Zhu, L. Ma, D. Zhang, K. Ray, W. Zhao, W. G. Humphreys, G. Skiles, M. Sanders, and H. Zhang Detection and Characterization of Metabolites in Biological Matrices Using Mass Defect Filtering of Liquid Chromatography/High Resolution Mass Spectrometry Data Drug Metab. Dispos., October 1, 2006; 34(10): 1722 - 1733. [Abstract] [Full Text] [PDF]

				S. E. Kostrubsky, S. C. Strom, A. S. Kalgutkar, S. Kulkarni, J. Atherton, R. Mireles, B. Feng, R. Kubik, J. Hanson, E. Urda, et al. Inhibition of Hepatobiliary Transport as a Predictive Method for Clinical Hepatotoxicity of Nefazodone Toxicol. Sci., April 1, 2006; 90(2): 451 - 459. [Abstract] [Full Text] [PDF]

				R. S. Obach, R. L. Walsky, K. Venkatakrishnan, E. A. Gaman, J. B. Houston, and L. M. Tremaine The Utility of in Vitro Cytochrome P450 Inhibition Data in the Prediction of Drug-Drug Interactions J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 336 - 348. [Abstract] [Full Text] [PDF]